Stockreport

ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology

ProPhase Labs, Inc.  (PRPH) 
US:NASDAQ Investor Relations: prophaselabs.com/investors/annual-reports
PDF Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- [Read more]